K. Krobot

发表

Real-World Effectiveness of Lipid-Lowering Therapy in Male and Female Outpatients with Coronary Heart Disease: Relation to Pre-Treatment Low-Density Lipoprotein-Cholesterol, Pre-Treatment Coronary Heart Disease Risk, and other Factors

E. Steinhagen-Thiessen, D. Yin, E. Alemao, 2005 .

Outpatient costs of osteoporosis in a national health insurance population.

W. Kirch, J. Krappweis, A. Rentsch, 1999, Clinical therapeutics.

Uwe Siebert secondary prevention patients using statins Risk factor levels , risk factor combinations , and residual coronary risk : population-based estimates for

U. Siebert, K. Krobot, A. Wagner, 2012 .

Company reference estimates for productivity loss due to migraine and productivity gains using rizatriptan 10 mg in Germany

H. Diener, Z. Katsarava, B. Liedert, 2006, International journal of clinical practice.

Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes

L. Gonder-Frederick, T. Stargardt, C. Alexander, 2009, Health and quality of life outcomes.

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study

G. Nocea, Ritesh N. Kumar, P. Mavros, 2013, Infection and drug resistance.

Cost of clinical events in health economic evaluations in Germany: a systematic review

V. Ulrich, K. Krobot, M. Scheuringer, 2012, Cost Effectiveness and Resource Allocation.

Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.

W. Gerth, R. Barnes, A. Ullmann, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

Mathias W Pletz, J. Maertens, G. Egerer, 2012, European Journal of Medical Research.

Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery

S. Sen, A. Altendorf-Hofmann, D. Yin, 2004, European Journal of Clinical Microbiology and Infectious Diseases.

Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany.

F. Lordick, K. Berger, R. Deuson, 2007, European journal of cancer.

Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany

G. Davies, K. Krobot, G. Michailov, 2011, The European Journal of Health Economics.

Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study.

S. Willich, H. Hahmann, K. Bestehorn, 2001, European heart journal.

Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors.

E. Steinhagen-Thiessen, D. Yin, E. Alemao, 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Simvastatin After Orthotopic Heart Transplantation

B. Reichart, K. Krobot, K. Wenke, 1999, PharmacoEconomics.

Regional variation in medication following coronary events in Germany.

S. Willich, H. Völler, J. Müller-Nordhorn, 2005, International journal of cardiology.

Lifetime Cost of Ischemic Stroke in Germany: Results and National Projections From a Population-Based Stroke Registry: The Erlangen Stroke Project

Bernhard Neundörfer, Martin Emmert, Peter L. Kolominsky-Rabas, 2006, Stroke.

The Disparity in Access to New Medication by Type of Health Insurance: Lessons From Germany

J. Kaufman, J. Preisser, W. Miller, 2004, Medical care.

Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA1c value

B. Goldstein, G. Meininger, K. Kaufman, 2012, Current medical research and opinion.

Heart failure/transplant: abstractSimvastatin initiated early after heart transplantation: 8-year prospective experience☆

G. Steinbeck, B. Meiser, B. Reichart, 2003 .